日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Host FSTL1 defines the impact of stem cell therapy on liver fibrosis by potentiating the early recruitment of inflammatory macrophages

宿主 FSTL1 通过增强炎症巨噬细胞的早期募集,决定干细胞疗法对肝纤维化的影响。

Zheng, Xiaohong; Tian, Siyuan; Li, Ting; Zhang, Si; Zhou, Xia; Liu, Yansheng; Su, Rui; Zhang, Miao; Li, Bo; Qi, Chao; Guo, Guanya; Ma, Shuoyi; Sun, Keshuai; Yang, Fangfang; Hu, Yinan; Yang, Chunmei; Cui, Lina; Shang, Yulong; Guo, Changcun; Jin, Boquan; Guan, Lei; Wang, Jingbo; Ning, Wen; Han, Ying

Engineered Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Mitigate Liver Fibrosis by Delivering USP10 to Reprogram Macrophage Phenotype.

工程化间充质干细胞衍生的小细胞外囊泡通过递送 USP10 重编程巨噬细胞表型来减轻肝纤维化

Tian Siyuan, Zhou Xia, Zheng Linhua, Liu Jingyi, Zhang Miao, Ma Shuoyi, Zheng Xiaohong, Guo Guanya, Ju Ruobing, Yang Fangfang, Liu Yansheng, Li Bo, Hu Yinan, Xia Erzhuo, Su Rui, Sun Keshuai, Cui Lina, Guo Changcun, Zhou Xinmin, Wang Jingbo, Shang Yulong, Han Ying

Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring system

识别失代偿期肝硬化患者自体外周血干细胞治疗的最佳候选者:预后评分系统

Tian, Siyuan; Guo, Guanya; Zhou, Xia; Liu, Yansheng; Jia, Gui; Zheng, Linhua; Cui, Lina; Wang, Kemei; Zhang, Miao; Sun, Keshuai; Ma, Shuoyi; Yang, Chunmei; Zhou, Xinmin; Guo, Changcun; Shang, Yulong; Han, Ying